Detail page

Knowledge Web

Person

Jesús Duque Afonso (1980-)

Name	Jesús Duque Afonso
Time	1980- (Date of birth and death)
Place	Santa Cruz de Tenerife (Geburtsort) Deutschland
Variant	Duque Jesús Afonso Atilio Jesús Duque Afonso Duque Atilio Jesús Afonso Jesús Duque-Afonso Jesús Duque- Afonso
Further information	Diss. 2011, Universität Freiburg, Medizinische Fakultät Habilitation 2020, Universität Freiburg, Medizinische Fakultät
Record type	Person
GND-Identifier	143525131
Record ID	143525131
Involved in show all Reduced intensity conditioning prior autologous stem cell transplantation in elderly DLBCL patients Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL Einfluss des VHL-1-HIF-1-Signalweges auf die Widerstandsfähigkeit von Caenorhabditis elegans gegenüber endoplasmatisch-retikulärem Stress Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning Identification of epigenetic modifiers essential for growth and survival of AML1/ETO‐positive leukemia Toxizität, Progressionsmuster und Überlebensdaten nach Strahlentherapie bei WHO Grad 3 Gliomen Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations Der Einfluss der Lungenfunktion auf autolog transplantierte Patienten mit Multiplem Myelom Functional characterization of transforming growth factor-[beta] signaling in dasatinib resistance and Pre-BCR+ acute lymphoblastic leukemia Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure Long-term outcomes of patients with relapse of juvenile myelomonocytic leukemia - analysis of the EWOG-MDS study Progenitor like cell type of an MLL-EDC4 fusion in acute myeloid leukemia Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation P328: Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressure P335: Genomic determinants of therapy response in ETV6-RUNX1 leukemia The epigenetics of breast cancer – Opportunities for diagnostics, risk stratification and therapy Untersuchung der Interaktion von pVHL und Histondeacetylasen sowie der regulierenden Wirkung der Acetyltransferase p300 auf den Transkriptionsfaktor NRF2 AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia Correction: Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia The impact of pulmonary function in patients undergoing autologous stem cell transplantation Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation Molekulare Pathogenese der chromosomalen Translokationen in akuten Leukämien Personalized treatment selection and disease monitoring using circulating tumor DNA profiling in real-world cancer patient management Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression Identifizierung und funktionelle Untersuchung von Zielgenen des Leukämie-spezifischen Transportfaktors AML1-ETO

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Jesús Duque Afonso (1980-)

Reduced intensity conditioning prior autologous stem cell transplantation in elderly DLBCL patients

Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors

Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors

Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL

Einfluss des VHL-1-HIF-1-Signalweges auf die Widerstandsfähigkeit von Caenorhabditis elegans gegenüber endoplasmatisch-retikulärem Stress

Evaluation of risk for bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens

Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning

Identification of epigenetic modifiers essential for growth and survival of AML1/ETO‐positive leukemia

Toxizität, Progressionsmuster und Überlebensdaten nach Strahlentherapie bei WHO Grad 3 Gliomen

Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure

Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party

Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations

Der Einfluss der Lungenfunktion auf autolog transplantierte Patienten mit Multiplem Myelom

Functional characterization of transforming growth factor-[beta] signaling in dasatinib resistance and Pre-BCR+ acute lymphoblastic leukemia

Long-term complete remission of refractory severe idiopathic immune thrombocytopenia (ITP) treated with daratumumab

Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure

Long-term outcomes of patients with relapse of juvenile myelomonocytic leukemia - analysis of the EWOG-MDS study

Progenitor like cell type of an MLL-EDC4 fusion in acute myeloid leukemia

Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia

Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party

Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party

Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia

Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation

P328: Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressure

P335: Genomic determinants of therapy response in ETV6-RUNX1 leukemia

The epigenetics of breast cancer – Opportunities for diagnostics, risk stratification and therapy

Untersuchung der Interaktion von pVHL und Histondeacetylasen sowie der regulierenden Wirkung der Acetyltransferase p300 auf den Transkriptionsfaktor NRF2

AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms

Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease

Correction to: Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

Correction: Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

The impact of pulmonary function in patients undergoing autologous stem cell transplantation

Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease

Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation

Molekulare Pathogenese der chromosomalen Translokationen in akuten Leukämien

Personalized treatment selection and disease monitoring using circulating tumor DNA profiling in real-world cancer patient management

Structured assessment of frailty in multiple myeloma as a paradigm of individualized treatment algorithms in cancer patients at advanced age

Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis

Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis

SETDB2 Links E2A-PBX1 to Cell-Cycle Dysregulation in Acute Leukemia through CDKN2C Repression

Identifizierung und funktionelle Untersuchung von Zielgenen des Leukämie-spezifischen Transportfaktors AML1-ETO